Oxford Biomedica PLC Holding(s) in Company (7574L)
October 05 2016 - 5:17AM
UK Regulatory
TIDMOXB
RNS Number : 7574L
Oxford Biomedica PLC
05 October 2016
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i)
----------------------------------------------------------------------------------------------
1. Identity of the issuer or OXFORD BIOMEDICA PLC
the underlying issuer
of existing shares to which
voting rights are
attached: (ii)
--------------------------------------------------------------- -----------------------------
2 Reason for the notification (please tick the appropriate
box or boxes):
----------------------------------------------------------------------------------------------
An acquisition or disposal of voting rights X
------------------------------------------------------------------ --------------------------
An acquisition or disposal of qualifying financial
instruments which may result in the acquisition
of shares already issued to which voting rights
are attached
------------------------------------------------------------------ --------------------------
An acquisition or disposal of instruments with
similar economic effect to qualifying financial
instruments
------------------------------------------------------------------ --------------------------
An event changing the breakdown of voting rights
------------------------------------------------------------------ --------------------------
Other (please
specify):
--------------------------------------------------------- ------- --------------------------
3. Full name of person(s) VULPES LIFE SCIENCES FUND
subject to the VULPES TESTUDO FUND
notification obligation:
(iii)
----------------------------------------------------------- ---------------------------------
4. Full name of shareholder(s)
(if different from 3.):(iv)
----------------------------------------------------------- ---------------------------------
5. Date of the transaction 04 OCT 2016
and date on
which the threshold is
crossed or
reached: (v)
----------------------------------------------------------- ---------------------------------
6. Date on which issuer 05 OCT 2016
notified:
----------------------------------------------------------- ---------------------------------
7. Threshold(s) that is/are >18%
crossed or
reached: (vi, vii)
----------------------------------------------------------- ---------------------------------
8. Notified details:
--------------------------------------------------------------------------------------------------------------------------
A: Voting rights attached to shares (viii, ix)
--------------------------------------------------------------------------------------------------------------------------
Class/type Situation previous Resulting situation after the
of to the triggering triggering transaction
shares transaction
if possible
using
the ISIN
CODE
------------- ---------------------------------- -----------------------------------------------------------------------
Number Number Number Number of voting % of voting
of of of shares rights rights (x)
Shares Voting
Rights
------------- ---------------- ---------------- -------------- ---------------------------- -------------------------
Direct Direct Indirect Direct Indirect
(xi) (xii)
------------- ------------ ------------ -------------- -------------- ------------ ------------ -----------
GB0006648157 475,807,928 475,807,928 575,850,000 575,850,000 18.65%
---------------- ---------------- -------------- -------------- ------------ ------------ -----------
B: Qualifying Financial Instruments
--------------------------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
--------------------------------------------------------------------------------------------------------------------------
Type of Expiration Exercise/ Number of voting % of voting
financial date Conversion rights that rights
instrument (xiii) Period (xiv) may be
acquired if
the
instrument is
exercised/ converted.
----------------- -------------- -------------------------------- ------------------------------ ---------------------
C: Financial Instruments with similar economic effect
to Qualifying Financial Instruments (xv, xvi)
--------------------------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
--------------------------------------------------------------------------------------------------------------------------
Type of Exercise Expiration Exercise/ Number of voting % of voting
financial price date Conversion rights instrument rights
instrument (xvii) period refers to (xix, xx)
(xviii)
--------------- -------------- -------------- ---------------- ------------------------------ -----------------------
Nominal Delta
--------------- -------------- -------------- ---------------- ------------------------------ ------------ ---------
Total (A+B+C)
--------------------------------------------------------------------------------------------------------------------------
Number of voting rights Percentage of voting rights
--------------------------------------------------- ---------------------------------------------------------------------
575,850,000 18.65%
--------------------------------------------------- ---------------------------------------------------------------------
9. Chain of controlled undertakings through which the
voting rights and/or the
financial instruments are effectively held, if applicable:
(xxi)
------------------------------------------------------------------------------------------
Proxy Voting:
------------------------------------------------------------------------------------------
10. Name of the proxy holder:
------------------------------------------------------------- ---------------------------
11. Number of voting rights proxy
holder will cease
to hold:
------------------------------------------------------------- ---------------------------
12. Date on which proxy holder will
cease to hold
voting rights:
------------------------------------------------------------- ---------------------------
13. Additional information:
------------------------------------------------------------- ---------------------------
14. Contact name: Tim Watts, Chief Financial
Officer
Oxford BioMedica
------------------------------------------------------------- ---------------------------
15. Contact telephone number: +44 (0) 1865 783 000
------------------------------------------------------------- ---------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLUVAKRNNARRRA
(END) Dow Jones Newswires
October 05, 2016 05:17 ET (09:17 GMT)
Oxford Biomedica (LSE:OXB)
Historical Stock Chart
From Mar 2024 to Apr 2024
Oxford Biomedica (LSE:OXB)
Historical Stock Chart
From Apr 2023 to Apr 2024
